Insulin resistance and atherosclerosis.
Considerable evidence supports the association between insulin resistance and vascular disease, and this has led to wide acceptance of the clustering of hyperlipidemia, glucose intolerance, hypertension, and obesity as a clinical entity, the metabolic syndrome. While insulin resistance, by promoting dyslipidemia and other metabolic abnormalities, is part of the proatherogenic milieu, it is possible that insulin resistance itself in the vascular wall does not promote atherosclerosis. Recent findings suggest that insulin resistance and atherosclerosis could represent independent and ultimately maladaptive responses to the disruption of cellular homeostasis caused by the excess delivery of fuel.
Semenkovich
Clay F
CF
Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri 63110, USA. csemenko@wustl.edu
D000818:Animals; D050197:Atherosclerosis / Q000503:physiopathology* / Q000628:therapy; D002467:Cell Nucleus / Q000378:metabolism; D050171:Dyslipidemias / Q000503:physiopathology; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology; D006973:Hypertension / Q000503:physiopathology; D007333:Insulin Resistance; D008928:Mitochondria / Q000378:metabolism; D018384:Oxidative Stress; D047492:Peroxisome Proliferator-Activated Receptors / Q000378:metabolism
D047492:Peroxisome Proliferator-Activated Receptors